You are here

  • Home
  • Archive
  • Volume 104, Issue 1
  • Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study

Article metrics

Article menu

Download PDFPDF

Clinical science
Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study

 

Online download statistics by month:

Online download statistics by month: April 2019 to September 2024

AbstractFullPdf
Apr 2019988978141
May 201910021006101
Jun 201967267199
Jul 2019681678101
Aug 201952952831
Sep 201944144139
Oct 201927427430
Nov 201919819834
Dec 201940740076
Jan 202056954369
Feb 202023722848
Mar 202018416538
Apr 202016915742
May 202014613651
Jun 202012912377
Jul 2020137133106
Aug 2020989147
Sep 202014013328
Oct 202013312644
Nov 202016216047
Dec 202015113835
Jan 20211029938
Feb 20211049528
Mar 2021999449
Apr 20211089723
May 202115614855
Jun 202111210440
Jul 202110410122
Aug 202114914920
Sep 2021958818
Oct 202113311943
Nov 2021857946
Dec 2021929225
Jan 2022848317
Feb 202210810817
Mar 2022889335
Apr 2022918715
May 20221009624
Jun 20229310032
Jul 2022464017
Aug 2022726919
Sep 2022666729
Oct 2022787210
Nov 2022484620
Dec 2022373013
Jan 2023645128
Feb 2023918132
Mar 2023484725
Apr 2023333038
May 2023766226
Jun 2023373414
Jul 2023423221
Aug 2023434039
Sep 2023352716
Oct 2023322116
Nov 2023686115
Dec 2023636025
Jan 2024373723
Feb 2024646423
Mar 2024474237
Apr 2024584823
May 2024514025
Jun 2024716617
Jul 2024575527
Aug 2024423821
Sep 2024504418
Total10806104432448